Amphastar Pharmaceuticals, Inc. Quarterly Long-term Debt and Lease Obligation in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Long-term Debt and Lease Obligation history and growth rate from Q4 2013 to Q3 2024.
  • Amphastar Pharmaceuticals, Inc. Long-term Debt and Lease Obligation for the quarter ending September 30, 2024 was $596M, a 6.54% decline year-over-year.
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $596M -$41.8M -6.54% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $587M +$98.6M +20.2% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $594M +$521M +715% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $590M +$517M +709% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $638M +$564M +762% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $488M +$414M +561% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $72.9M -$1.48M -1.99% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $72.8M -$1.94M -2.59% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $74M -$1.54M -2.04% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $73.9M +$43.4M +143% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $74.3M +$42M +130% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $74.8M +$40.6M +119% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $75.6M +$42.6M +130% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $30.5M -$4.16M -12% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $32.3M -$4.08M -11.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $34.2M -$5.21M -13.2% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $32.9M -$5.18M -13.6% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $34.6M -$5.17M -13% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $36.4M +$5.44M +17.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $39.4M +$7.41M +23.2% Dec 31, 2019 10-K 2021-03-15
Q3 2019 $38.1M +$5.47M +16.8% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $39.8M +$6.1M +18.1% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $31M -$8.73M -22% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $32M -$8.86M -21.7% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $32.6M -$9.63M -22.8% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $33.7M -$6.41M -16% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $39.7M +$8.56M +27.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $40.8M +$8.49M +26.2% Dec 31, 2017 10-K 2019-03-15
Q3 2017 $42.2M +$8.07M +23.6% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $40.1M +$8.37M +26.4% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $31.1M +$2.06M +7.07% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $32.4M +$2.19M +7.26% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $34.2M +$2.81M +8.96% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $31.7M -$3.06M -8.78% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $29.1M -$6.79M -18.9% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $30.2M -$5.94M -16.5% Dec 31, 2015 10-K 2017-03-15
Q3 2015 $31.4M -$9.92M -24% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $34.8M -$8.05M -18.8% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $35.9M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $36.1M +$26M +259% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $41.3M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $42.9M Jun 30, 2014 10-Q 2014-08-13
Q4 2013 $10.1M Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.